Back to Jefferies Financial Group Inc. Jefferies Financial Group Inc.

ATYRATYR

4 quarters

Position history for Jefferies Financial Group Inc.Jefferies Financial Group Inc.'s holdings in aTyr Pharma, Inc.

No. Jefferies Financial Group exited its ATYR (aTyr Pharma) position in Q2 2025. Its Q1 2025 13F listed 55,600 shares worth $167,912. Jefferies Financial Group first reported ATYR in Q3 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$97,856

Total Shares Change

-55,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$5.07
0
2025-Q1
Unchanged
55,600
0.0%
$167,9120.0%$3.02
0
2024-Q4
Unchanged
55,600
0.0%
$201,2720.0%$3.62
0
2024-Q3
New
55,600
—
$97,8560.0%$1.76
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used